1. Home
  2. FLNC vs IOVA Comparison

FLNC vs IOVA Comparison

Compare FLNC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$19.77

Market Cap

1.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNC
IOVA
Founded
2018
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
FLNC
IOVA
Price
$19.77
$4.25
Analyst Decision
Hold
Buy
Analyst Count
17
10
Target Price
$15.71
$9.00
AVG Volume (30 Days)
12.6M
12.9M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$2,262,830,000.00
N/A
Revenue This Year
$51.23
$47.74
Revenue Next Year
$21.30
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$1.67
52 Week High
$33.51
$5.63

Technical Indicators

Market Signals
Indicator
FLNC
IOVA
Relative Strength Index (RSI) 43.61 56.07
Support Level $18.90 $2.07
Resistance Level $23.90 $4.35
Average True Range (ATR) 3.14 0.37
MACD -0.64 0.02
Stochastic Oscillator 3.51 51.00

Price Performance

Historical Comparison
FLNC
IOVA

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: